/home/arranoyd/mail/new/1727189019.M415632P1358349.dike1.altushost.com,S=7066,W=7223
Envelope-to: arranoyd@dike1.altushost.com
Delivery-date: Tue, 24 Sep 2024 16:43:39 +0200
Date: Tue, 24 Sep 2024 14:38:50 +0000 (UTC)
From: MAILER-DAEMON@mailchannels.net (Mail Delivery System)
Subject: Undelivered Mail Returned to Sender
To: arranoyd@dike1.altushost.com
Auto-Submitted: auto-replied
MIME-Version: 1.0
Content-Type: multipart/report; report-type=delivery-status;
	boundary="9DB96454CE.1727188730/relay.mailchannels.net"
Content-Transfer-Encoding: 8bit
Message-Id: <20240924143850.8C4E344E80@relay.mailchannels.net>

This is a MIME-encapsulated message.

--9DB96454CE.1727188730/relay.mailchannels.net
Content-Description: Notification
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: 8bit

This is the mail system at host relay.mailchannels.net.

I'm sorry to have to inform you that your message could not
be delivered to one or more recipients. It's attached below.

For further assistance, please send mail to postmaster.

If you do so, please include this problem report. You can
delete your own text from the attached returned message.

                   The mail system

<support@qodeinteractive.com>: host mx10.ewdhosting.com[206.220.174.26] said:
    550 Message rejected due to user rules. (in reply to end of DATA command)

--9DB96454CE.1727188730/relay.mailchannels.net
Content-Description: Delivery report
Content-Type: message/delivery-status

Reporting-MTA: dns; relay.mailchannels.net
X-Postfix-Queue-ID: 9DB96454CE
X-Postfix-Sender: rfc822; arranoyd@dike1.altushost.com
Arrival-Date: Tue, 24 Sep 2024 14:38:47 +0000 (UTC)

Final-Recipient: rfc822; support@qodeinteractive.com
Original-Recipient: rfc822;support@qodeinteractive.com
Action: failed
Status: 5.0.0
Remote-MTA: dns; mx10.ewdhosting.com
Diagnostic-Code: smtp; 550 Message rejected due to user rules.

--9DB96454CE.1727188730/relay.mailchannels.net
Content-Description: Undelivered Message
Content-Type: message/rfc822
Content-Transfer-Encoding: 8bit

Return-Path: <arranoyd@dike1.altushost.com>
Received: from relay.mailchannels.net (localhost [127.0.0.1])
	by relay.mailchannels.net (Postfix) with ESMTP id 9DB96454CE
	for <support@qodeinteractive.com>; Tue, 24 Sep 2024 14:38:47 +0000 (UTC)
Received: from dike1.altushost.com (trex-6.trex.outbound.svc.cluster.local [100.99.101.23])
	(Authenticated sender: altushostbv)
	by relay.mailchannels.net (Postfix) with ESMTPA id F3E4A45487
	for <support@qodeinteractive.com>; Tue, 24 Sep 2024 14:38:46 +0000 (UTC)
ARC-Seal: i=1; s=arc-2022; d=mailchannels.net; t=1727188727; a=rsa-sha256;
	cv=none;
	b=j4umKANQjfx6Z7uBUIcXqU51pCojfV+2CQ/HrKZFv0iRyzSwRfh2VLPgtAcca0p0ZPzvDK
	ge09B6DlCPUSf3pWaP3KtJYxJSFBRU0CM8YoDPO98zGfSgIfscdGS9sT3k4BDS84Rh2l4A
	hkPNKVvvJ3lj9NC7RqyZ8RPMtkq1v9gCM5XUhCQTl1apJMiQTcNfH8dv/bHKw5mSQETSxI
	Xf/+PGFwleVa6fv2wpbw91hDsJSFXylXcwRpLjvF+J6aNPoGZ/OHGubX02SzXDgT0LHCBl
	dZMawhSYVL1jgizQC/5unYgRxm+Vcu3VwSiTF6h+Mk5BMSIYOZdE32qncAe40Q==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed;
 d=mailchannels.net;
	s=arc-2022; t=1727188727;
	h=from:from:reply-to:subject:subject:date:date:message-id:message-id:
	 to:to:cc:mime-version:mime-version:content-type:content-type:
	 dkim-signature; bh=TSI8xQ4kbgrxfLsh+9pjydWpQURebbPrXZeHvEbPCjA=;
	b=mxn+ZeVu6CAEIQrmOm8d/1paPdjQAVAQlmvqSp8wlMEkvgk8LQgnUoxG0jy7faHEqeE3TB
	v6kMFjbIdL+SoDLFUVjAL1cmDBJQBrrvWLcm11nCd3O7e5J7esNbe7EdIhLI9ScjgT/mrJ
	lV/mou8KFrLM6JZSGJbzj4bE+4+h/Ldkzx90NTi2FeIXGKm4KU7ot9x0VsKIkDFixgXHK3
	V1KUUofqyaDZ0ZlWeZq3mIrszeVRMz0Akj62Rz5/yOn8ErNiNIxpB6HJWgKZ2eLWUMxSti
	XXY/0bPq2UsiD6uS8Jum/uVmU/+fsjTRKBPXS6d8SaTQsQ3zY10Jjd8E+O4piw==
ARC-Authentication-Results: i=1;
	rspamd-5b46bcd97f-hq6wg;
	auth=pass smtp.auth=altushostbv smtp.mailfrom=arranoyd@dike1.altushost.com
X-Sender-Id: altushostbv|x-authuser|arranoyd@dike1.altushost.com
X-MC-Relay: Neutral
X-MailChannels-SenderId: altushostbv|x-authuser|arranoyd@dike1.altushost.com
X-MailChannels-Auth-Id: altushostbv
X-Slimy-Whistle: 1dbb0faa64052b29_1727188727521_2628150104
X-MC-Loop-Signature: 1727188727521:2645851491
X-MC-Ingress-Time: 1727188727520
Received: from dike1.altushost.com (dike1.altushost.com [91.214.47.200])
	(using TLSv1.3 with cipher TLS_AES_256_GCM_SHA384)
	by 100.99.101.23 (trex/7.0.2);
	Tue, 24 Sep 2024 14:38:47 +0000
DKIM-Signature: v=1; a=rsa-sha256; q=dns/txt; c=relaxed/relaxed; d=arra.no;
	s=default; h=Content-Type:MIME-Version:Message-ID:From:Date:Subject:To:Sender
	:Reply-To:Cc:Content-Transfer-Encoding:Content-ID:Content-Description:
	Resent-Date:Resent-From:Resent-Sender:Resent-To:Resent-Cc:Resent-Message-ID:
	In-Reply-To:References:List-Id:List-Help:List-Unsubscribe:List-Subscribe:
	List-Post:List-Owner:List-Archive;
	bh=TSI8xQ4kbgrxfLsh+9pjydWpQURebbPrXZeHvEbPCjA=; b=gyJzlo92E1wBhfzvhUp7HmKSOS
	BlqGR4V9p8fAXXitB8WEbJsSqcfiyoImzQSSd5rG0bJwCVvp/LLMW4U78zX8Bf/mMJnjAKrkS58ui
	R0J/SjG0O1+hRQ2DVrm1teT0QrK5WqNRMUskYissWsE+R10uYFI6RIwb5vzVo6MACIqGPLAZANAPY
	xSsqiHuk8zjQOiCV0VpwLhQAXQvtRmbd9EJYoViIWzK7NWszAyTkctohLFVdCFgROKc4N+ibTQQrl
	OJoumQSN7dU87Atwn3FARpp74iQYpOAMjMQ8g6/LVjhdcjM213nXkRNLjR/crbsd+hunaP9KAG/gZ
	DpJFIWRg==;
Received: from arranoyd by dike1.altushost.com with local (Exim 4.96.2)
	(envelope-from <arranoyd@dike1.altushost.com>)
	id 1st6gf-005gGb-0f
	for support@qodeinteractive.com;
	Tue, 24 Sep 2024 16:38:45 +0200
To: support@qodeinteractive.com
Subject: Bridge "[your-subject]"
X-PHP-Script: stopostoprirodno.hr/index.php for 37.139.53.167, 172.69.192.173, 37.139.53.167
X-PHP-Originating-Script: 1015:class-phpmailer.php
Date: Tue, 24 Sep 2024 14:38:45 +0000
From: purgigo <wordpress@bridge191.qodeinteractive.com>
Message-ID: <8b034dc666cd6ecc8ec802a7458016b3@stopostoprirodno.hr>
X-Mailer: PHPMailer 5.2.27 (https://github.com/PHPMailer/PHPMailer)
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
X-AuthUser: arranoyd@dike1.altushost.com

From: purgigo <[your-email]>
Subject: [your-subject]

Message Body:
<a href=https://enhanceyourlife.mom/>priligy online</a> Thanks to a large number of cancer registries that record new cancer diagnoses and follow individuals forward from the point of diagnosis, 5 year survival rates for people initially diagnosed with cancer are widely available to provide evidence about the success of detection and treatment

-- 
This e-mail was sent from a contact form on Bridge (http://bridge191.qodeinteractive.com)


--9DB96454CE.1727188730/relay.mailchannels.net--